• Scanfil: Scanfil: Fin(n)ishing off the year in solid fashion – Q4 initial (Carnegie)
    2025-02-21 08:33
  • Raysearch Laboratories: Raysearch Laboratories rapport i linje med förväntningarna (Pinpoint Estimates)
    2025-02-21 08:31
  • Godsinlösen Nordic: Analys GIAB: Sund kärnaffär riskerar rekonstruktion (Carlsquare)
    2025-02-21 08:15
  • Kreate Group: Kreate has filed a compensation claim against Solwers' subsidiary (Inderes)
    2025-02-21 08:13
  • Tecnotree: Tecnotree Q4'24 preview: Spotlight on outlook for cash flow and geographic expansion (Inderes)
    2025-02-21 08:03
  • Veteranpoolen: Veteranpoolens rörelseresultat under förväntningarna (Pinpoint Estimates)
    2025-02-21 08:02
  • Anora Group: Anora: Good growth from Viva Wine, the main competitor in wines, in Q4 as usual (Inderes)
    2025-02-21 07:48
  • Cavotec: Cavotec - Strong order intake and improved profitability (ABG Sundal Collier)
    2025-02-21 07:45
  • Better Collective: Better Collective: Increased focus on organic growth (Redeye)
    2025-02-21 07:42
  • Job Solution Sweden Holding: Job Solution: Keeps outgrowing the staffing market – Q4 review (Carnegie)
    2025-02-21 07:41
  • Björn Borg: Björn Borg: Högre tillväxt och lägre lönsamhet än väntat (Pinpoint Estimates)
    2025-02-21 07:40
  • Lifecare: Lifecare Q4 2024: Setting the stage (Redeye)
    2025-02-21 07:30
  • Viva Wine: Research update Viva Wine Group Q4, Q4 2024: Positive growth momentum should continue (Carlsquare)
    2025-02-21 07:25
  • Fable Media Group: Fable Media Group: Solid 2025 guidance (Redeye)
    2025-02-21 07:25
  • Alcadon Group: Alcadon: Time to use the useful toolbox - SEB (SEB Research)
    2025-02-21 07:23
  • Gofore: Gofore: Harvesting cash when the market is slow - SEB (SEB Research)
    2025-02-21 07:22
  • Scanfil: Scanfils Q4 Report in Line with Expectations (Pinpoint Estimates)
    2025-02-21 07:18
  • Navigo Invest: Navigo Invest: Intervju med vd Oscar Rolfsson (Redeye)
    2025-02-21 07:15
  • Cinclus Pharma: Cinclus Pharma: Intervju med vd Christer Ahlberg (Redeye)
    2025-02-21 07:15
  • Infracom Group: InfraCom: Intervju med vd Bo Kjellberg (Redeye)
    2025-02-21 07:15
  • W5 Solutions: W5 Solutions: Highlights from our defence event (Carnegie)
    2025-02-21 07:15
  • KebNi: Kebni: Highlights from our defence event (Carnegie)
    2025-02-21 07:08
  • Q4 likely to shore up 2024 (Nordea)
    2025-02-21 07:01
  • MilDef Group: MilDef Group: Highlights from our defence event (Carnegie)
    2025-02-21 07:01
  • Navigo Invest: Navigo Q4 2024: 2025e could represent a turning point (Redeye)
    2025-02-21 07:00
  • Dignitana: Dignitana Q4’24: Improving sales momentum (Redeye)
    2025-02-21 07:00
  • Ferronordic: Better than feared but margins under pressure (Nordea)
    2025-02-21 07:00
  • Infracom Group: InfraCom: Resurgence with solid results and attractive valuation (Redeye)
    2025-02-21 07:00
  • Beyond Frames Entertainment: Beyond Frames: Heading into an eventful 2025 on a high note – Q4 review (Carnegie)
    2025-02-21 06:54
  • Teneo.ai: Teneo AI: Scalable Growth Highlighted (Redeye)
    2025-02-21 06:45
  • Viscaria: Viscaria - Expects permit finalised during the spring (ABG Sundal Collier)
    2025-02-20 20:00
  • Clavister Holding: Clavister - A new breakthrough partnership (ABG Sundal Collier)
    2025-02-20 19:31
  • Ferronordic: Ferronordic - Germany still weighs while US performs (ABG Sundal Collier)
    2025-02-20 19:30
  • VO2 Cap Holding: VO2 Cap Holding: Purchase optionality a substantial valuation upside (Carnegie)
    2025-02-20 19:05
  • Coor Service Management Holding: Coor - Disappointing, but issues should be fixable (ABG Sundal Collier)
    2025-02-20 18:01
  • G5 Entertainment: G5 Entertainment - Better organic growth on the horizon (ABG Sundal Collier)
    2025-02-20 18:00
  • Cinclus Pharma: Cinclus Pharma: Ask questions to Redeye's analyst (Redeye)
    2025-02-20 17:30
  • Vivesto: Vivesto: Intervju – Statusuppdatering efter Q4 2024-rapporten (Carnegie)
    2025-02-20 17:10
  • Waystream Group: Waystream : Intervju – Interna åtgärder motverkar en svag marknad (Carnegie)
    2025-02-20 17:10
  • ALM Equity: ALM Equity: Intervju – Fokus på exekvering under 2025 (Carnegie)
    2025-02-20 16:55